Petney® is indicated for feline and canines patients diagnosed with International Renal Interest Society (IRIS) stages 2 to 4 chronic kidney disease (CKD). Its purpose is to ameliorate clinical symptoms, safeguard residual renal function, and mitigate the potential for sustained deterioration in renal function, thereby diminishing the likelihood of progression to end-stage kidney disease (ESKD).

Petney is a trademark of Mutian Life Sciences Bio Co.,Ltd